Page last updated: 2024-10-16

adenine and Leiomyosarcoma, Epithelioid

adenine has been researched along with Leiomyosarcoma, Epithelioid in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Twenty-six evaluable patients who had leiomyosarcoma of the uterus were treated with amonafide, 300 mg/m2, for 5 consecutive days every 3 weeks."9.08Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study. ( Asbury, R; Blessing, JA; Buller, R; Malfetano, JH; Sevin, BU; Walker, J, 1998)
"Twenty-six evaluable patients who had leiomyosarcoma of the uterus were treated with amonafide, 300 mg/m2, for 5 consecutive days every 3 weeks."5.08Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study. ( Asbury, R; Blessing, JA; Buller, R; Malfetano, JH; Sevin, BU; Walker, J, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asbury, R1
Blessing, JA1
Buller, R1
Malfetano, JH1
Walker, J1
Sevin, BU1

Trials

1 trial available for adenine and Leiomyosarcoma, Epithelioid

ArticleYear
Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study.
    American journal of clinical oncology, 1998, Volume: 21, Issue:2

    Topics: Adenine; Adult; Aged; Antineoplastic Agents; Female; Humans; Imides; Isoquinolines; Leiomyosarcoma;

1998